Johnson & Johnson, U.S. agree on drug discounts, new plants
Key Terms
tariffs
regulatory
Tariffs are taxes imposed by a government on goods…
Kennedy’s SSRI rhetoric fuels distrust amid teen mental health crisis
While his war on vaccines may be getting more attention, health secretary Robert F. Kennedy Jr. is coming…
Opinion: America’s new vaccine doctrine for children replaces data with dogma
Outside the BoxThe Trump administration has dropped recommendations for six vaccines and one preventative therapy for all children…
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
TEL AVIV, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today…
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the…
Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026
Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael…
Novo Nordisk beyond weight loss has investors wary, scientists hopeful
Ozempic is medicine for adults with type 2 diabetes that along with diet and exercise may improve blood…
Artificial intelligence unlocks new frontiers in RNA drug design
In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in…
LLY inches up as weight-loss pill pricing, insider filing keep spotlight on obesity drugs
NEW YORK, December 29, 2025, 17:45 ET — After-hours Shares of Eli Lilly and Company (LLY) were up…
STAT staffers share stories they wish they had written in 2025
This year saw upheaval in all corners of health, science, and biotech. While our staff was covering all…
U.S. vaccine policy could see big changes in 2026
WASHINGTON — Vaccine policy has become a key issue for the Trump administration, especially under the leadership of…
Eight Roads-backed PlasmaGen Bio snags funding, valuation nears $170 mn
Plasmagen Biosciences CEO Vivek Kamath PlasmaGen Biosciences, a biopharmaceutical company which counts investors such as Eight Roads Ventures…